Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of HIST2H2BE mRNA] | affects expression|affects reaction | 19414516
|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of HIST2H2BE mRNA] | affects expression|affects reaction | 19414516
|
D000242 |
Cyclic AMP |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of HIST2H2BE mRNA] | affects expression|affects reaction | 19414516
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HIST2H2BE mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HIST2H2BE mRNA | increases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HIST2H2BE mRNA | decreases expression | 20127859
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HIST2H2BE mRNA | increases expression | 20382639 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of HIST2H2BE mRNA | decreases expression | 16474171
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of HIST2H2BE mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in decreased expression of HIST2H2BE mRNA | decreases expression | 16474171
|
D019833 |
Genistein |
Genistein results in decreased expression of HIST2H2BE mRNA | decreases expression | 16474171
|
D007529 |
Isoflavones |
Isoflavones affects the expression of HIST2H2BE mRNA | affects expression | 16365062
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in increased expression of HIST2H2BE mRNA | increases expression | 20024957
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in decreased expression of HIST2H2BE mRNA | decreases expression | 16474171
|
C059514 |
resveratrol |
resveratrol results in decreased expression of HIST2H2BE mRNA | decreases expression | 19371625
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HIST2H2BE mRNA | increases expression | 12679051
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HIST2H2BE mRNA | increases expression | 16249480
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.88 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.13 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.13 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
7.13 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.86 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.86 | 15688382 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.76 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.96 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
9.65 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
9.65 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.57 | 16183991 16162502 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.57 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.57 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.35 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.29 | 17967414 16873680 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.64 | 16197459 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.33 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.98 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.98 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.98 | 16675129 17289903 17261762 12948864 18497071 19861407 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.98 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.98 | 17651959 17534123 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.98 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.51 | 16111702 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.94 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
8.94 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.94 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.94 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.94 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.64 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.88 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.88 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.88 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.88 | 16051514 16096774 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
12.46 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
12.46 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
12.46 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.11 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
21.33 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
21.33 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
21.33 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
21.33 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
21.33 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.64 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.94 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.68 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
9.77 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.77 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.95 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.95 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
3.74 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
3.74 | 15531428 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.74 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.77 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 17551590 14991402 16925845 9664655 10589399 9142499 9224671 8800419 9125849 9211117 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.73 | 16140633 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.79 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.49 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.10 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.10 | 16286809 |
MESH:D004487 |
Edema |
|
resveratrol |
3.39 | 8985016 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.53 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.06 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.64 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.58 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.58 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.58 | 16569247 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.89 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.37 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.37 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.60 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.88 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.83 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.73 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.27 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.27 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.20 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.70 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.70 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.09 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.23 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.18 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.63 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
10.63 | 17290160 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.23 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.03 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.06 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.11 | 10903974 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.33 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.69 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.01 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
resveratrol |
2.86 | 16366677 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.61 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.50 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.50 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.93 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.15 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.15 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.15 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.35 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.46 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.46 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.73 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.83 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.83 | 16823087 17506722 17712046 19225113 16788101 17217047 19035177 16331271 19642359 16935935 9834237 19029980 19075265 17368321 17107899 15748426 17294898 12679006 17649720 16766008 16891316 17301526 17361223 16140955 17339181 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.57 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.57 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.57 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.58 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.58 | 19812893 19321006 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.58 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
3.62 | 1423854 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.19 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.06 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.43 | 18816296 6695378 20064080 20135361 20464547 17053015 18569708 20869020 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.43 | 16712894 19931552 17306315 17077188 15276417 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.33 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.89 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.30 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.15 | 16891317 11807958 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.15 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
10.15 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.55 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.19 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.19 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.19 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.19 | 18303189 16966607 16166281 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.41 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
5.19 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.49 | 14749477 17164350 16490592 16267019 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.92 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.09 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
6.04 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.04 | 17125593 16525036 16317513 17188708 17015251 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
4.03 | 17125593 17015251 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.58 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.58 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.81 | 17322642 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.34 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.34 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.34 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
9.37 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.37 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.78 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
23.81 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
23.81 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
23.81 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
23.81 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.37 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.37 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.83 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.43 | 17929310 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.65 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.65 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
10.26 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
10.26 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.37 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.37 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.37 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.37 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.92 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.47 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.40 | 16702228 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.93 | 10923243 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.04 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
10.04 | 16679765 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.65 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.65 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.48 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.48 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.48 | 17374662 17571952 17219775 16365062 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.48 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.48 | 17804756 15767336 17675339 16731767 17636462 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.48 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.04 | 15814490 17365031 17322281 17975199 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.65 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.28 | 16314181 17058453 15827377 16317513 17520802 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.13 | 16116481 16283617 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.38 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.70 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.70 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.70 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.70 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.82 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.35 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.35 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.51 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.05 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.75 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
10.00 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.00 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.51 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
8.51 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.51 | 16452187 11723127 17306315 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
16.06 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
16.06 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
16.06 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.17 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.67 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.47 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.34 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |